Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood–brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies

References

• Anand O, Yu LX, Conner DP, Davit BM. Dissolution testing for generic drugs: An FDA perspective. AAPS J, 2011;13:328–35
   PubMed Web of Science ®Google Scholar
• Awotwe-Otoo D, Agarabi C, Keire D, Lee S, Raw A, Yu L, Habib MJ, Khan MA, Shah RB. Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sources. AAPS J, 2012;14:619–26
   Google Scholar
• Bickel U. Antibody delivery through the blood–brain barrier. Adv Drug Deliv Rev, 1995;15:53–72
   Google Scholar
• Brown RE, Jarvis KL, Hyland KJ. Protein measurement using bicinchoninic acid: Elimination of interfering substances. Anal Biochem, 1989;180:136–9
   PubMed Web of Science ®Google Scholar
• Carrielo NF, Swenberg JA, Skopek TR. In vitro mutational specificity of cisplatin in the human hypoxanthine guanine phosphoribosyl transferase gene. Cancer Res, 1992;52:2866–73
   Google Scholar
• Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: Effect of administration route and magnetic field topography. J Control Release, 2011;155:393–9
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int J Pharm, 2007;342:208–14
   PubMed Web of Science ®Google Scholar
• Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, Kaube H, Volker L, Thomale J. Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci, 2007;27:9451–7
   PubMed Web of Science ®Google Scholar
• Flores AL, Jurado R, Lopez PG. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell and tumor samples. J Pharmacol Toxicol Methods, 2005;52:366–72
   Google Scholar
• Georgieva JV, Kalicharan D, Couraud PO, Romero IA, Weksler B, Hoekstra D, Zuhorn IS. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther, 2011;19:318–25
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT, Perrier DG. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci, 1987;76:141–5
   PubMed Web of Science ®Google Scholar
• Herve F, Ghinea N, Scherrmann JM. CNS delivery via adsorptive transcytosis. AAPS J, 2008;10:455–72
   PubMed Web of Science ®Google Scholar
• Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res, 2002;19:1488–94
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP. Development of a single dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol, 2004;56:1243–50
   PubMed Web of Science ®Google Scholar
• Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(dl-lactide-co-glycolide). J Microencapsul, 2005;22:593–601
   PubMed Web of Science ®Google Scholar
• Jiang Y, Shi K, Xia D, Piao H, Quan P, Song T, Cui F. Protamine modified metal ionprotein chelate microparticles for sustained release of interferon. Int J Pharm, 2011;407:31–7
   Google Scholar
• Kaminski R, Darbinyan A, Merabova N, Deshmane SL, White MK, Khalili K. Protective role of Purα to cisplatin. Cancer Biol Ther, 2008;7:1926–35
   PubMed Web of Science ®Google Scholar
• Kashi TSJ, Eskandarion S, Dinarvand R. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine, 2012;7:221–34
   PubMed Web of Science ®Google Scholar
• Ke CJ, Chiang WL, Liao ZX, Chen HL, Lai PS, Sun JS, Sung HW. Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance. Biomaterials, 2013;34:1–10
   PubMed Web of Science ®Google Scholar
• Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release, 2007;120:18–26
   PubMed Web of Science ®Google Scholar
• Kumagai AK, Eisenberg JB, Pardridge WM. Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. J Biol Chem, 1987;262:15214–19
   PubMed Web of Science ®Google Scholar
• Landen JW, Hau V, Wang M, Davis T, Ciliax B, Wainer BH, Meir EGV, Glass JD, Joshi HC, Archer DR. Noscapine crosses the blood–brain barrier and inhibits glioblastoma growth. Clin Cancer Res, 2004;10:5187–201
   PubMed Web of Science ®Google Scholar
• Long DF, Repta AJ. Cisplatin: chemistry, distribution and biotransformation. Biopharm Drug Disposition, 1981;2:1–16
   PubMed Web of Science ®Google Scholar
• Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res, 2006;66:11878–87
   PubMed Web of Science ®Google Scholar
• Lua L, Petera SJ, Lymanb MD, Laib HL, Leiteb SM, Tamadab JA, Uyamac S, Vacantic JP, Langerb R, Mikos AG. In vitro and in vivo degradation of porous poly (dl-lactic-coglycolic acid) foams. Biomaterials, 2000;21:1837–45
   Google Scholar
• Madan J, Pandey RS, Jain V, Katare OP, Chandra R, Katyal A. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. Nanomedicine, 2013;9:492–503
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int J Pharm, 2005;290:137–44
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 2011;3:1377–97
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983;65:55–63
   PubMed Web of Science ®Google Scholar
• Ozolek JA, Jane EP, Krowsoski L, Sammak PJ. Human embryonic stem cells (HSF-6) show greater proliferation and apoptosis when grown on glioblastoma cells than mouse embryonic fibroblasts at day 19 in culture: Comparison of proliferation, survival, and neural differentiation on two different feeder cell types. Stem Cell Dev, 2007;16:403–12
   Google Scholar
• Paraskara AS, Sonia S, Chinc KT, Chaudhuria P, Mutoc KW, Berkowitzc J, Handlogtend MW, Alvesd NJ, Bilgicerd B, Dinulescub DM, et al. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proc Natl Acad Sci USA, 2010;107:12435–40
   Google Scholar
• Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnol, 2012;10:20–35
   PubMed Web of Science ®Google Scholar
• Regberg J, Srimanee A, Langel U. Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. Pharmaceuticals, 2012;5:991–1007
   Google Scholar
• Rybak LP, Mukherjee D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: Clinical and experimental Studies. Tohoku J Exp Med, 2009;219:177–86
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 2002;82:105–14
   PubMed Web of Science ®Google Scholar
• Schuldes H, Bade S, Knobloch J, Jonas D. Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperatures. Cancer, 1997;79:1723–8
   Google Scholar
• Taghavi MS, Akbarzadeh A, Mahdian R, Azadmanesh K, Javadi G. Cisplatin down regulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells. In Vitro Cell Dev Biol Anim, 2013;49:465–72
   Google Scholar
• Wang JH, Bartlett JD, Dunn AC, Small S, Willis SL, Driver MJ, Lewis AL. The use of rhodamine 6G and fluorescence microscopy in the evaluation of phospholipid-based polymeric biomaterials. J Microsc, 2005;217:216–24
   PubMed Web of Science ®Google Scholar
• Xia H, Gao X, Gu G, Liu Z, Zeng N, Hu Q, Song Q, Yao L, Pang Z, Jiang X, et al. Recent progress in fluorescent and colorimetric chemosensors for detection of precious metal ions (silver, gold and platinum ions). Chem Soc Rev, 2011;40:3416–29
   Google Scholar
• Zhua X, Lua L, Curriera BL, Windebankb AJ, Yaszemski MJ. Controlled release of NFkB decoy oligonucleotides from biodegradable polymer microparticles. Biomaterials, 2002;23:2683–92
   Google Scholar
• Zustovich F, Lombardi G, Puppa AD, Rotilio A, Scienza R, Pastorelli D. A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomiderefractory high-grade malignant glioma. Anticancer Res, 2009;29:4275–80
   PubMed Web of Science ®Google Scholar